Associated Papers
Single-nucleotide m⁶A mapping uncovers redundant YTHDF function in planarian progenitor fate selection.
Yesharim Y et al.
The Embo Journal, 2026
Mechanosensitive snoRNA-like circular RNA sno-circCNOT1 drives endothelial dysfunction and atherosclerosis.
Bi L et al.
Theranostics, 2026
RMVar 2.0: an updated database of functional variants in RNA modifications.
Huang Y et al.
Nucleic Acids Research, 2025
Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.
Zhang C et al.
Science Advances, 2024
The theory of massively repeated evolution and full identifications of cancer-driving nucleotides (CDNs).
Zhang L et al.
Elife, 2024
METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer.
Bai X et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2024
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer.
Shoemaker R et al.
Nar Cancer, 2024
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions.
Zhang C et al.
Cancer Metastasis Reviews, 2023
A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.
Miyake K et al.
Cell Reports, 2023
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells.
Hou Y et al.
Embo Reports, 2023
Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.
Zhang C et al.
Biorxiv : the Preprint Server for Biology, 2023
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma.
Liu X et al.
Bioengineered, 2022
RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases.
Willbanks A et al.
Genes, 2021
Spatially interacting phosphorylation sites and mutations in cancer.
Huang KL et al.
Nature Communications, 2021
RMVar: an updated database of functional variants involved in RNA modifications.
Luo X et al.
Nucleic Acids Research, 2021
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.
Punta M et al.
Frontiers in Immunology, 2020
Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM et al.
Bmc Medical Genomics, 2019
Next-Generation Sequencing.
Le Gallo M et al.
Advances in Experimental Medicine and Biology, 2017
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Gnad F et al.
Bmc Genomics, 2015
Novel genetic targets in endometrial cancer.
Bell DW
Expert Opinion on Therapeutic Targets, 2014